'Inactivated vaccine' presentation slideshows

Surveillance: The Public Health Version of CSI

Surveillance: The Public Health Version of CSI. March 2006 Connie Austin and Judy Conway Illinois Department of Public Health. Outline of Surveillance Talk. Basics of Surveillance Uses of Surveillance Limitations of Surveillance Future of Surveillance

1.61k views • 124 slides

Travel Associated Infections

888 views • 49 slides

FL U

FL U. The underestimated threat. Dr Esteghamati. Influenza Virus Types. Type A humans and other animals all age groups moderate to severe illness Type B milder epidemics humans only primarily affects children Type C - uncommon strain, no epidemic. Increased Risk. Age 65 and older

447 views • 39 slides

Part IV: H5N1 Human Outbreaks

Part IV: H5N1 Human Outbreaks. Avian Influenza A(H5N1), 1997 . Avian Influenza A(H5N1) caused 18 cases of influenza with 6 deaths in the Hong Kong area. Experts are concerned that the virus may acquire a mutation encouraging human-to-human transmission. . The H5N1 Influenza Pandemic Threat.

598 views • 37 slides

Influenza Vaccination Policies and Procedures

Influenza Vaccination Policies and Procedures. Indiana State Department of Health November 2009. Glossary. Multi dose Vial (MDV) : 5mL vial contains at least 10 .5mL doses of vaccine Prefilled Syringes (PFS) : Syringes arrive prefilled with vaccine for either .25mL or .5mL dose

316 views • 31 slides

Poliomyelitis

Poliomyelitis. First described by Michael Underwood in 1789 First outbreak described in U.S. in 1843 21,000 paralytic cases reported in the U. S. in 1952 Global eradication in near future. Poliovirus. Enterovirus (RNA) Three serotypes: 1, 2, 3

628 views • 22 slides

Instructions for users

Instructions for users. This slide presentation provides an overview of the control of JE and prevention of JE by immunization. Below many of the slides, there are notes to explain the information in the slide. You should adapt the presentation for your own use.

205 views • 20 slides

Instructions for users

Instructions for users. This slide presentation provides an overview of the control of JE and prevention of JE by immunization. Below many of the slides, there are notes to explain the information in the slide. You should adapt the presentation for your own use.

283 views • 19 slides

Vaccine types

Live vaccines use a weakened (or attenuated) form of the germ that causes a disease. Because these vaccines are so similar to the natural infection that they help prevent, they create a strong and long-lasting immune response. Just 1 or 2 doses of most live vaccines can give you a lifetime of protection against a germ and the disease it causes.

149 views • 8 slides

Vaccines

Well development of a vaccine project requires an experienced partner who understands the unique complexity presented by this important research area. Close cooperation between professional laboratories and clinical research teams is essential for ensuring good sample handling, tracking and data reporting, and successful completion of vaccine research.

107 views • 7 slides